Literature DB >> 11277590

Motor imagery in normal subjects and Parkinson's disease patients: an H215O PET study.

M Samuel1, A O Ceballos-Baumann, H Boecker, D J Brooks.   

Abstract

Motor imagery paradigms can be used to investigate motor preparation. We used positron emission tomography to compare regional cerebral blood flow (rCBF) in patients with Parkinson's disease and normal controls under three conditions: rest, motor imagery and motor execution. In controls, imagery activated bilateral dorsolateral and mesial frontal cortex, inferior parietal cortex and precuneus. Motor execution additionally activated primary motor cortex (p < 0.001). Between-group, for imagery there was relative reduction in dorsolateral and mesial frontal activation in the patient group (p<0.01). For execution, there was impaired activation of right dorsolateral frontal cortex and basal ganglia (p<0.01). Our results support the notion that underfunctioning of mesial frontal and dorsolateral prefrontal cortex may underlie motor preparation in Parkinson's disease but also suggest that akinesia may occur in the absence of impaired mesial frontal cortex activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277590     DOI: 10.1097/00001756-200103260-00040

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Brain areas activated in fMRI during self-regulation of slow cortical potentials (SCPs).

Authors:  Thilo Hinterberger; Ralf Veit; Ute Strehl; Tracy Trevorrow; Michael Erb; Boris Kotchoubey; Herta Flor; Niels Birbaumer
Journal:  Exp Brain Res       Date:  2003-06-27       Impact factor: 1.972

2.  Neural substrates of levodopa-responsive gait disorders and freezing in advanced Parkinson's disease: a kinesthetic imagery approach.

Authors:  Audrey Maillet; Stéphane Thobois; Valérie Fraix; Jérôme Redouté; Didier Le Bars; Franck Lavenne; Philippe Derost; Franck Durif; Bastiaan R Bloem; Paul Krack; Pierre Pollak; Bettina Debû
Journal:  Hum Brain Mapp       Date:  2014-11-19       Impact factor: 5.038

3.  Non-dominant hand movement facilitates the frontal N30 somatosensory evoked potential.

Authors:  Wynn Legon; Jennifer K Dionne; Sean K Meehan; W Richard Staines
Journal:  BMC Neurosci       Date:  2010-09-07       Impact factor: 3.288

4.  Corticomotor facilitation associated with observation and imagery of hand actions is impaired in Parkinson's disease.

Authors:  François Tremblay; Guillaume Léonard; Louis Tremblay
Journal:  Exp Brain Res       Date:  2007-10-10       Impact factor: 1.972

5.  Effects of levodopa on vividness of motor imagery in Parkinson disease.

Authors:  Daniel S Peterson; Kristen A Pickett; Gammon M Earhart
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

Review 6.  Impact of neurologic deficits on motor imagery: a systematic review of clinical evaluations.

Authors:  Franck Di Rienzo; Christian Collet; Nady Hoyek; Aymeric Guillot
Journal:  Neuropsychol Rev       Date:  2014-04-04       Impact factor: 7.444

7.  Brain network involved in visual processing of movement stimuli used in upper limb robotic training: an fMRI study.

Authors:  Federico Nocchi; Simone Gazzellini; Carmela Grisolia; Maurizio Petrarca; Vittorio Cannatà; Paolo Cappa; Tommaso D'Alessio; Enrico Castelli
Journal:  J Neuroeng Rehabil       Date:  2012-07-24       Impact factor: 4.262

8.  Imagining is Not Doing but Involves Specific Motor Commands: A Review of Experimental Data Related to Motor Inhibition.

Authors:  Aymeric Guillot; Franck Di Rienzo; Tadhg Macintyre; Aidan Moran; Christian Collet
Journal:  Front Hum Neurosci       Date:  2012-09-05       Impact factor: 3.169

Review 9.  Functional and anatomical magnetic resonance imaging in Parkinson's disease.

Authors:  Alain Dagher; Atsuko Nagano-Saito
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.484

10.  Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.

Authors:  Garrett E Alexander
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.